NCT00974012View on ClinicalTrials.gov

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Divalproex Sodium

500 mg ER Tablet

DRUG

Depakote®

500 mg ER Tablet

Trial Locations (1)

56721

PRACS Institute, Ltd., East Grand Forks

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00974012 - Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter